Clincosm LogoSign in Get a demo

Type 2 Diabetes

Showing NaN - NaN of 74
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Type 2 Diabetes Trial in United States (Produce Prescription)

Enrolling by invitation
  • Type 2 Diabetes
  • Produce Prescription
  • Chicago, Illinois
  • +4 more
Oct 3, 2023

Overweight or Obesity, CKD, Type 2 Diabetes Trial in Worldwide (LY3437943, Placebo)

Not yet recruiting
  • Overweight or Obesity
  • +2 more
  • Canoga Park, California
  • +19 more
Jun 30, 2023

Type 2 Diabetes, Obesity, Overweight or Obesity Trial in Worldwide (Orforglipron, Insulin Glargine)

Recruiting
  • Type 2 Diabetes
  • +5 more
  • Muscle Shoals, Alabama
  • +320 more
Apr 12, 2023

Prostate Specific Antigen Screening, Asymptomatic Bacteriuria, Type 2 Diabetes Trial in Chicago (EHR clinical decision support

Completed
  • Prostate Specific Antigen Screening
  • +2 more
  • EHR clinical decision support nudges
  • Brief clinician education
  • Chicago, Illinois
    Northwestern Medicine
Nov 22, 2022

Type 2 Diabetes Trial in Worldwide (Tirzepatide, Insulin Lispro (U100), Insulin Glargine (U100))

Completed
  • Type 2 Diabetes
  • Sheffield, Alabama
  • +134 more
Nov 22, 2022

Type 2 Diabetes Trial in United States (Automated health education using a digital health pathway)

Recruiting
  • Type 2 Diabetes
  • Automated health education using a digital health pathway
  • Chicago, Illinois
  • +3 more
Sep 16, 2022

Type 2 Diabetes Trial in Worldwide (Dulaglutide, Placebo)

Completed
Has Results
  • Type 2 Diabetes
  • Birmingham, Alabama
  • +60 more
Jun 7, 2022

Type 2 Diabetes, Sleep, Stress Trial in Chicago (Mindfunlness Meditation)

Recruiting
  • Type 2 Diabetes
  • +2 more
  • Mindfunlness Meditation
  • Chicago, Illinois
    University of Illinois at Chicago
May 24, 2022

Type 2 Diabetes Trial in Worldwide (Mylan's insulin glargine, Lantus®)

Completed
Has Results
  • Type 2 Diabetes
  • Chandler, Arizona
  • +119 more
Mar 1, 2022

Type 2 Diabetes Trial in United States (BT-001, Physician-guided Standard of Care for type 2 diabetes)

Active, not recruiting
  • Type 2 Diabetes
  • BT-001
  • Physician-guided Standard of Care for type 2 diabetes
  • San Francisco, California
  • +5 more
Jan 13, 2022

Type 2 Diabetes Trial in Chicago (My Diabetes Goal, My Diabetes Goal + CommunityRx)

Recruiting
  • Type 2 Diabetes
  • My Diabetes Goal
  • My Diabetes Goal + CommunityRx
  • Chicago, Illinois
    University of Chicago Medicine
Aug 27, 2021

Type 2 Diabetes, Diabetes, Type 2, Type 2 Diabetes in Obese Trial in Chicago (Aerobic exercise training)

Recruiting
  • Type 2 Diabetes
  • +2 more
  • Aerobic exercise training
  • Chicago, Illinois
    University of Illinois at Chicago
Jun 8, 2021

Type 2 Diabetes Trial in United States (Rivoglitazone, Pioglitazone, Placebo)

Completed
  • Type 2 Diabetes
  • Birmingham, Alabama
  • +73 more
May 6, 2021

Type 2 Diabetes, Self-regulation Trial in Chicago (Feasibility group)

Terminated
  • Type 2 Diabetes
  • Self-regulation
  • Feasibility group
  • Chicago, Illinois
    University of Illinois at Chicago, College of Nursing
Apr 28, 2021

Type 2 Diabetes Trial in Worldwide (Placebo, Exenatide)

Completed
Has Results
  • Type 2 Diabetes
  • Birmingham, Alabama
  • +52 more
Nov 6, 2020

Cardiovascular Disease, High Cardiovascular Risk, Obesity Trial in Worldwide (Lorcaserin HCl, Placebo)

Completed
Has Results
  • Cardiovascular Disease
  • +4 more
  • Lorcaserin hydrochloride
  • Placebo
  • Alexander City, Alabama
  • +498 more
Jun 27, 2019

Type 2 Diabetes Trial in United States (Salsalate, Placebo)

Completed
Has Results
  • Type 2 Diabetes
  • New Haven, Connecticut
  • +15 more
Mar 25, 2019

Type 2 Diabetes Trial in Chicago (UMS Strategy, SMS Texting Reminders)

Completed
Has Results
  • Type 2 Diabetes
  • UMS Strategy
  • SMS Texting Reminders
  • Chicago, Illinois
    Northwestern University
Dec 10, 2018

Type 2 Diabetes Trial in United States (ITCA 650 (exenatide in DUROS))

Terminated
  • Type 2 Diabetes
  • ITCA 650 (exenatide in DUROS)
  • Birmingham, Alabama
  • +50 more
Mar 4, 2019

Type 2 Diabetes Trial in United States (Linagliptin, Basal Bolus, Linagliptin + 50% Glargine dose on discharge)

Completed
Has Results
  • Type 2 Diabetes
  • Denver, Colorado
  • +4 more
Feb 18, 2019

Type 2 Diabetes, Sleep Disordered Breathing Trial in Chicago (Exenatide, Placebo)

Completed
Has Results
  • Type 2 Diabetes
  • Sleep Disordered Breathing
  • Chicago, Illinois
  • +1 more
Aug 16, 2018

Prediabetes, Type 2 Diabetes Trial in Chicago, Indianapolis, Seattle (Metformin, Liraglutide, Glargine)

Unknown status
  • Prediabetes
  • Type 2 Diabetes
  • Chicago, Illinois
  • +3 more
Aug 29, 2018

Hypercholesterolemia, Mixed Dyslipidemia, Type 2 Diabetes Trial in Worldwide (Evolocumab, Placebo to Evolocumab)

Completed
Has Results
  • Hypercholesterolemia
  • +2 more
  • Evolocumab
  • Placebo to Evolocumab
  • Tuscumbia, Alabama
  • +65 more
Aug 2, 2018

Type 2 Diabetes Trial in Worldwide (Saxagliptin, Dapagliflozin, Sitagliptin)

Completed
Has Results
  • Type 2 Diabetes
  • Mesa, Arizona
  • +78 more
May 29, 2018

Type 2 Diabetes Trial in Worldwide (Saxagliptin, Metformin XR, Dapagliflozin)

Completed
Has Results
  • Type 2 Diabetes
  • Birmingham, Alabama
  • +138 more
Mar 29, 2017